共 50 条
Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation
被引:10
|作者:
Vyas, Bhawna
[1
]
Singh, Manjinder
[2
]
Kaur, Maninder
[2
]
Bahia, Malkeet Singh
[2
]
Jaggi, Amteshwar Singh
[3
]
Silakari, Om
[2
]
Singh, Baldev
[1
]
机构:
[1] Punjabi Univ, Dept Chem, Patiala 147002, Punjab, India
[2] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Mol Modeling Lab, Patiala 147002, Punjab, India
[3] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Div Pharmacol, Patiala 147002, Punjab, India
关键词:
Atom-based;
3D-QSAR;
Docking analysis;
Aldose reductase (ALR2);
Flavonoid derivatives;
Diabetic complications;
RESOLUTION DRUG DESIGN;
TYROSINE KINASE SYK;
DIFFERENTIAL INHIBITION;
SELECTIVE INHIBITORS;
CRYSTAL-STRUCTURE;
POLYOL PATHWAY;
QSAR;
DERIVATIVES;
DOCKING;
PHARMACOPHORE;
D O I:
10.1016/j.jmgm.2015.03.005
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
Herein, atom-based 3D-QSAR analysis was performed using receptor-guided alignment of 46 flavonoid inhibitors of aldose reductase (ALR2) enzyme. 3D-QSAR models were generated in PHASE programme, and the best model corresponding to PLS factor four (QSAR(4)), was selected based on different statistical parameters (i.e., R-train(2), 0.96; Q(test)(2) 0.81; SD, 0.26). The contour plots of different structural properties generated from the selected model were utilized for the designing of five new congener molecules. These designed molecules were duly synthesized, and evaluated for their in vitro ALR2 inhibitory activity that resulted in the micromolar (IC50 < 22 mu M) activity of all molecules. Thus, the newly designed molecules having ALR inhibitory potential could be employed for the management of diabetic complications. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:59 / 71
页数:13
相关论文